EKSO vs. SOTK, LBGJ, TRSG, FTEK, ZOOZ, CVV, TRT, SHMD, GTEC, and LIQT
Should you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include Sono-Tek (SOTK), Li Bang International (LBGJ), Tungray Technologies (TRSG), Fuel Tech (FTEK), ZOOZ Power (ZOOZ), CVD Equipment (CVV), Trio-Tech International (TRT), SCHMID Group (SHMD), Greenland Technologies (GTEC), and LiqTech International (LIQT). These companies are all part of the "machinery" industry.
Ekso Bionics vs.
Sono-Tek (NASDAQ:SOTK) and Ekso Bionics (NASDAQ:EKSO) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings.
Sono-Tek has a net margin of 5.47% compared to Ekso Bionics' net margin of -62.95%. Sono-Tek's return on equity of 6.55% beat Ekso Bionics' return on equity.
Sono-Tek has higher revenue and earnings than Ekso Bionics. Ekso Bionics is trading at a lower price-to-earnings ratio than Sono-Tek, indicating that it is currently the more affordable of the two stocks.
Sono-Tek has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, Ekso Bionics has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500.
Sono-Tek presently has a consensus price target of $7.50, indicating a potential upside of 91.33%. Ekso Bionics has a consensus price target of $5.50, indicating a potential upside of 744.21%. Given Ekso Bionics' higher possible upside, analysts plainly believe Ekso Bionics is more favorable than Sono-Tek.
47.9% of Sono-Tek shares are held by institutional investors. Comparatively, 6.4% of Ekso Bionics shares are held by institutional investors. 5.9% of Sono-Tek shares are held by company insiders. Comparatively, 6.1% of Ekso Bionics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Sono-Tek had 10 more articles in the media than Ekso Bionics. MarketBeat recorded 15 mentions for Sono-Tek and 5 mentions for Ekso Bionics. Sono-Tek's average media sentiment score of 0.47 beat Ekso Bionics' score of 0.05 indicating that Sono-Tek is being referred to more favorably in the media.
Ekso Bionics received 213 more outperform votes than Sono-Tek when rated by MarketBeat users. However, 65.09% of users gave Sono-Tek an outperform vote while only 55.12% of users gave Ekso Bionics an outperform vote.
Summary
Sono-Tek beats Ekso Bionics on 11 of the 16 factors compared between the two stocks.
Get Ekso Bionics News Delivered to You Automatically
Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ekso Bionics Competitors List
Related Companies and Tools
This page (NASDAQ:EKSO) was last updated on 1/21/2025 by MarketBeat.com Staff
